Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Tecres S.P.A. — Predicate Candidate Screening
14 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
248 daysmedian FDA review time
654 days90th percentile
14clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K252326 | InterSpace GV Hip Spacer | Tecres S.P.A. | 2025-08-06 | 12 | 0 |
| K211163 | Bone Cement Genta, Bone Cement HV, Bone Cement LV | Tecres S.P.A. | 2023-01-09 | 630 | 0 |
| K220131 | KYPHON VuE Bone Cement | Tecres S.P.A. | 2022-04-18 | 90 | 0 |
| K181732 | InterSpace Knee Extra-Large Size, InterSpace Knee ATS | Tecres S.P.A. | 2019-04-27 | 299 | 0 |
| K122175 | MENDEC SPINE HV, MENDEC SPINE HV SYSTEM | Tecres S.P.A. | 2013-03-28 | 248 | 0 |
| K112983 | SPACER-S | Tecres S.P.A. | 2011-12-12 | 67 | 0 |
| K101356 | Spacer-G and Spacer-K | Tecres S.P.A. | 2011-09-20 | 494 | 0 |
| K092773 | CEMEX GENTA, GENTA SYSTEM AND GENTA SYSTEM FAST | Tecres S.P.A. | 2009-11-24 | 76 | 0 |
| K062273 | SPACER-G TEMPORARY HIP PROSTHESIS | Tecres S.P.A. | 2008-05-22 | 654 | 0 |
| K062274 | SPACER-K TEMPORARY KNEE SPACER WITH GENTAMICIN, MODELS SPK00 | Tecres S.P.A. | 2008-05-22 | 654 | 0 |
| K063438 | VSPSPN | Tecres S.P.A. | 2007-01-17 | 64 | 0 |
| K062452 | KIT MENDEC SPINE AND DELIVERY SYSTEM | Tecres S.P.A. | 2006-09-21 | 30 | 0 |
| K060535 | SPACER-S TEMPORARY SHOULDER SPACER | Tecres S.P.A. | 2006-05-24 | 85 | 0 |
| K042415 | MENDEC SPINE | Tecres S.P.A. | 2005-06-09 | 275 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda